Dudediligence.

BioAtla, Inc

BCABNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$10.6MSep ’24−$14.9MDec ’24−$15.3MMar ’25−$18.7MJun ’25−$15.8MSep ’25$109.4MDec ’25−$6.3MMar ’26$452,000Jun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$300,000none on filenone on filenone on filenone on file
Operating income−$96.4M−$108.1M−$129.7M−$73.9M−$59.3M
Net income−$95.4M−$106.5M−$123.5M−$69.8M$59.6M
Operating cash flow−$62.2M−$90.4M−$104.0M−$71.9M−$48.2M
Cash$245.0M$215.5M$111.5M$49.0M$7.1M
Shares outstanding35.8M46.3M48.1M58.1M63.5M